The Effect of Maternal Voice and Music Therapy on Pain and Stress During Heel Prick Testing in Newborns
The Effect of Maternal Voice and Music Therapy on Pain and Stress During Heel Prick Testing in Newborns: A Randomised Controlled Trial
研究概览
详细说明
It has been noted that one of the non-pharmacological methods used in effective pain management in children is the mother's voice. Although the mechanism underlying the effect of the mother's voice is not fully understood, it is stated that the mother's voice creates a calming environment for children. Studies have shown that listening to the mother's voice before and after invasive procedures performed on infants and children in intensive care units reduces pain. In a study conducted by Erdoğan et al., it was found that children aged 1-3 years who listened to their mother's voice during painful procedures had lower pain levels, lower heart rates, and higher oxygen saturation. It is emphasized that in critical care settings where mothers cannot be with their babies and children and cannot actively participate in their care, listening to the mother's voice is one of the approaches that can be used as an effective method in pain management.
It is known that non-pharmacological methods are effective in reducing pain in children and that they increase the effectiveness of drugs when used together with analgesics. Non-pharmacological methods are preferred because they are easy to apply and inexpensive, reduce the need for drug administration and thus the risk of side effects. Developing appropriate pain control strategies by knowing the effect of pain and related stress on children is both a medical and ethical responsibility.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Fulya Merve FMK KOS, Assis Prof Dr
- 电话号码:05300974816
- 邮箱:fulya.kos@bilecik.edu.tr
学习地点
-
-
Turkey
-
Bilecik、Turkey、土耳其(türkiye)、11230
- Bilecik Seyh Edebali University
-
接触:
- Fulya KOS
- 电话号码:05300974816
- 邮箱:fulya.kos@bilecik.edu.tr
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
接受健康志愿者
描述
Inclusion Criteria:
- Newborns within the first 24-48 hours after birth or 7-14 days old
- At least 2 hours after the last painful intervention
- Children whose parents agreed to participate in the study were included.
Exclusion Criteria:
- Presence of hearing impairment
- Absence of Parental Consent Form
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:The Effect of Maternal Voice and Music Therapy on Pain and Stress
The Effect of Maternal Voice and Music Therapy on Pain and Stress During Heel Prick Testing in Newborns
|
In the group where Music Therapy will be applied, the heel prick blood test procedure and the study will be explained to the newborn and their parents.
After obtaining consent, music therapy will be applied to the newborn 5 minutes before, during, and after the procedure.
During this time, data will be recorded on a form by the observer.
The song "The Happiest Child," developed by Fulya Merve KOS, a researcher with a Rhythm Therapist™ certificate issued by the Ministry of National Education, will be used in music therapy.
The sound will be adjusted to 45 dB.
The speaker will be placed at the tip of the newborn's foot, approximately 30 cm away from their ear, five minutes before the procedure and played to the child during the procedure.
This sound will be played to the child 5 minutes before, during, and 5 minutes after the heel prick blood test, and data will be recorded by two observers and evaluated using the Newborn Infant Pain Scale (NIPS) and the Newborn Stress Scale.
In the group where the mother's voice will be used, the child's parents will be informed that the mother's voice will be used for pain relief in the study.
For each newborn whose heel prick blood sample is taken by the researcher, the mother's voice will be recorded using a voice recorder.
To play the mother's voice, the voice recorder will be placed 50 cm away from the child and the measurement will be taken.
The sound level of the mother's voice will be set to an average of 45 decibels.
The speaker will be placed at the tip of the newborn's foot, approximately 30 cm away from the ear, five minutes before the procedure and will be played to the child during the procedure.
The child will be played this voice 5 minutes before, during, and 5 minutes after the heel prick blood sample is taken.
Data will be recorded by two observers and evaluated using the Neonatal Infant Pain Scale (NIPS) and the Neonatal Stress Scale.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Neonatal Infant Pain Scale
大体时间:Baseline / Pre-encounter
|
The Neonatal Infant Pain Scale (NIPS) was developed by Lawrence et al. (1993) and adapted into Turkish by Akdovan (1999).
It is a pain assessment scale developed for preterm and newborn infants, which evaluates the behavioural response to pain during invasive procedures.
The total score on the NIPS ranges from 0 to 7, with scores above 3 indicating the presence of pain.
|
Baseline / Pre-encounter
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Neonatal Stress Scale
大体时间:Baseline / Pre-encounter
|
The Neonatal Stress Scale was developed by Ceylan and Bolışık (2017) to assess stress levels in premature infants.
The scale consists of 24 items in total, including 8 subgroups covering facial expression, body color, respiration, activity level, soothing ability, muscle tone, extremities, and posture, using a 3-point Likert scale.
Each subgroup is scored between 0 and 2 points.
The minimum score on the scale is 0, and the maximum is 16.
An increase in the score indicates an increased stress level in the infant.
The scale is evaluated through observation.
It is sufficient for the infant to exhibit only one of the behaviors in each cell of the scale for scoring.
When the infant exhibits both of the signs (behaviors) in two different cells during observation (for example, when the infant exhibits signs corresponding to both 1 and 2 points), the highest value is valid.
An infant whose condition is stable and balanced will receive a score of 0 on the scale.
Infants b
|
Baseline / Pre-encounter
|
合作者和调查者
出版物和有用的链接
一般刊物
- No publications resulting from this study are available at this time as the trial is currently ongoing.
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- Bilecik-BSEU4
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Individual Participant Data (IPD) will not be made publicly available or shared for this study due to ethical considerations regarding participant confidentiality and the explicit terms of the informed consent protocol.
Specifically:
Informed Consent Constraints: The informed consent forms approved by the Institutional Review Board (IRB) / Ethics Committee and signed by the parents/guardians do not include permissions for raw, individual-level data sharing with external third parties or public repositories.
Privacy and Vulnerability: Given that the study population consists of pediatric patients undergoing clinical evaluations, raw IPD contains sensitive demographic and clinical details that could potentially compromise participant anonymity.
De-identified aggregate statistical data, protocol details, and final study findings will be made available through published peer-reviewed journal articles and clinical trial registries upon study completion.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.